Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.1.1 Rising prevalence of Gastro-Intestinal diseases.
4.1.1.2 Preference for minimally invasive surgeries
4.1.1.3 Technological developments in capsule endoscopes.
4.1.2 Restraints
4.1.2.1 Raising ethical issues in medical conditions
4.1.2.2 Lack of skilled professionals.
4.1.2.3 High cost.
4.1.3 Opportunities
4.1.3.1 Precisely locate chronic diseases and disorders.
4.1.4 Challenges
4.1.4.1 Reduce side effects
4.1.4.2Cost effective pills
Chapter 6 Market Segmentation by Type
6.1 IntelliCap CR
6.2 IntelliCap FR
Chapter 6 Market Segmentation by Geography
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.1.5 Others
6.2 Europe
6.2.1 Introduction
6.2.2 Spain
6.2.3 UK
6.2.4 France
6.2.5 Germany
6.2.6 Italy
6.2.7 Scandinavia
6.2.8 BENELUX
6.2.9 Others
6.3 Asia Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia & New Zealand
6.3.6 Others
6.4 The Middle East and Africa
6.4.1 Introduction
6.4.2 South Africa
6.4.3 Middle East Countries
6.4.4 Others
6.5 South America
6.5.1 Introduction
6.5.2 Argentina
6.5.3 Brazil
6.5.4 Others
Chapter 7 Competitive Landscape
7.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
7.2 Market Share Analysis
7.3 Strategies Adopted By Top Companies
Chapter 8 Company Profiles
8.1 Azoi
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiative
8.2 IntroMedic Co., Ltd.,
8.3 MicroChips
8.4 AdhereTech
8.5 GE Healthcare
8.6 Given Imaging Ltd
8.7 Proteus Pharmaceuticals
8.8 Olympus Medical Technology
8.9 Boston Scientific Corporation
8.10 Vitality
8.11 Capsovision Inc.
8.12 Pixie Scientific
8.13 Medisafe
8.14 Medimetrics S.A. De C.V.
8.15 Bio-Images Research Ltd
Chapter 9 Market Estimates and Forecasting
9.1 Market Estimates and Forecasting 2018-2024(USD Million)
9.1.1 Market Estimation and Forecasting by Type 2018-2024 (USD Million)
9.1.2 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 10 Market Insights
10.1 Insights of Industry Experts
10.2 Analyst Opinion (Market Understanding)
10.3 Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
